{"id":"https://openalex.org/W15106902","doi":"https://doi.org/10.1515/acph-2015-0002","title":"Potential antiproliferative effect of isoxazolo- and thiazolo coumarin derivatives on breast cancer mediated bone and lung metastases","display_name":"Potential antiproliferative effect of isoxazolo- and thiazolo coumarin derivatives on breast cancer mediated bone and lung metastases","publication_year":2015,"publication_date":"2015-03-01","ids":{"openalex":"https://openalex.org/W15106902","doi":"https://doi.org/10.1515/acph-2015-0002","mag":"15106902","pmid":"https://pubmed.ncbi.nlm.nih.gov/25781704"},"language":"en","primary_location":{"id":"doi:10.1515/acph-2015-0002","doi":"https://doi.org/10.1515/acph-2015-0002","is_oa":true,"landing_page_url":"https://doi.org/10.1515/acph-2015-0002","pdf_url":"https://sciendo.com/pdf/10.1515/acph-2015-0002","source":{"id":"https://openalex.org/S6622299","display_name":"Acta Pharmaceutica","issn_l":"1330-0075","issn":["1330-0075","1846-9558"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","medline","norway-1","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320322","host_organization_name":"De Gruyter Open","host_organization_lineage":["https://openalex.org/P4310320322","https://openalex.org/P4310313990"],"host_organization_lineage_names":["De Gruyter Open","De Gruyter"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta Pharmaceutica","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W15106902"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","datacite","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://sciendo.com/pdf/10.1515/acph-2015-0002","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5067296179","display_name":"Lulzime Ballazhi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I76245029","display_name":"Ss. Cyril and Methodius University in Skopje","ror":"https://ror.org/02wk2vx54","country_code":"MK","type":"education","lineage":["https://openalex.org/I76245029"]}],"countries":["MK"],"is_corresponding":false,"raw_author_name":"Lulzime Ballazhi","raw_affiliation_strings":["Institute of Pharmaceutical Chemistry Faculty of Pharmacy University \u00bbSs. Cyril and Methodius\u00ab 1000 Skopje, Republic of Macedonia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Pharmaceutical Chemistry Faculty of Pharmacy University \u00bbSs. Cyril and Methodius\u00ab 1000 Skopje, Republic of Macedonia","institution_ids":["https://openalex.org/I76245029"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061055066","display_name":"Emil Popovski","orcid":"https://orcid.org/0000-0002-6673-0917","observed_orcids":["https://orcid.org/0000-0002-6673-0917"]},"institutions":[{"id":"https://openalex.org/I76245029","display_name":"Ss. Cyril and Methodius University in Skopje","ror":"https://ror.org/02wk2vx54","country_code":"MK","type":"education","lineage":["https://openalex.org/I76245029"]}],"countries":["MK"],"is_corresponding":false,"raw_author_name":"Emil Popovski","raw_affiliation_strings":["Institute of Chemistry, Faculty of Natural Sciences and Mathematics University \u00bbSs. Cyril and Methodius\u00ab PO Box 162, 1000 Skopje Republic of Macedonia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Chemistry, Faculty of Natural Sciences and Mathematics University \u00bbSs. Cyril and Methodius\u00ab PO Box 162, 1000 Skopje Republic of Macedonia","institution_ids":["https://openalex.org/I76245029"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043454284","display_name":"Ahmed Jashari","orcid":"https://orcid.org/0000-0003-1915-3296","observed_orcids":["https://orcid.org/0000-0003-1915-3296"]},"institutions":[{"id":"https://openalex.org/I124793430","display_name":"State University of Tetova","ror":"https://ror.org/01e4kx996","country_code":"MK","type":"education","lineage":["https://openalex.org/I124793430"]}],"countries":["MK"],"is_corresponding":false,"raw_author_name":"Ahmed Jashari","raw_affiliation_strings":["Faculty of Natural Sciences and Mathematics, State University of Tetovo 1200 Tetovo, Republic of Macedonia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Natural Sciences and Mathematics, State University of Tetovo 1200 Tetovo, Republic of Macedonia","institution_ids":["https://openalex.org/I124793430"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079149492","display_name":"Faik Imeri","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118564535","display_name":"University of Bern","ror":"https://ror.org/02k7v4d05","country_code":"CH","type":"education","lineage":["https://openalex.org/I118564535"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Faik Imeri","raw_affiliation_strings":["Institute of Pharmacology, University of Bern, CH-3010 Bern, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Pharmacology, University of Bern, CH-3010 Bern, Switzerland","institution_ids":["https://openalex.org/I118564535"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Ibrahim Ibrahimi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I124793430","display_name":"State University of Tetova","ror":"https://ror.org/01e4kx996","country_code":"MK","type":"education","lineage":["https://openalex.org/I124793430"]}],"countries":["MK"],"is_corresponding":false,"raw_author_name":"Ibrahim Ibrahimi","raw_affiliation_strings":["Faculty of Medical Sciences, State University of Tetovo, 1200 Tetovo, Republic of Macedonia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Medical Sciences, State University of Tetovo, 1200 Tetovo, Republic of Macedonia","institution_ids":["https://openalex.org/I124793430"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110540165","display_name":"B. M. Mikhova","orcid":"https://orcid.org/0000-0001-8851-971X","observed_orcids":["https://orcid.org/0000-0001-8851-971X"]},"institutions":[{"id":"https://openalex.org/I24768866","display_name":"Bulgarian Academy of Sciences","ror":"https://ror.org/01x8hew03","country_code":"BG","type":"government","lineage":["https://openalex.org/I24768866"]},{"id":"https://openalex.org/I4210094418","display_name":"Institute of Organic Chemistry with Centre of Phytochemistry","ror":"https://ror.org/00jbx2e92","country_code":"BG","type":"facility","lineage":["https://openalex.org/I24768866","https://openalex.org/I4210094418"]}],"countries":["BG"],"is_corresponding":false,"raw_author_name":"Bozhana Mikhova","raw_affiliation_strings":["Institute of Organic Chemistry with Centre of Phytochemistry Bulgarian Academy of Sciences 1113 Sofia, Bulgaria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Organic Chemistry with Centre of Phytochemistry Bulgarian Academy of Sciences 1113 Sofia, Bulgaria","institution_ids":["https://openalex.org/I24768866","https://openalex.org/I4210094418"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5054921818","display_name":"Kristina Mladenovska","orcid":"https://orcid.org/0000-0003-2503-4699","observed_orcids":["https://orcid.org/0000-0003-2503-4699"]},"institutions":[{"id":"https://openalex.org/I76245029","display_name":"Ss. Cyril and Methodius University in Skopje","ror":"https://ror.org/02wk2vx54","country_code":"MK","type":"education","lineage":["https://openalex.org/I76245029"]}],"countries":["MK"],"is_corresponding":false,"raw_author_name":"Kristina Mladenovska","raw_affiliation_strings":["Institute of Pharmaceutical Chemistry Faculty of Pharmacy University \u00bbSs. Cyril and Methodius\u00ab 1000 Skopje, Republic of Macedonia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Pharmaceutical Chemistry Faculty of Pharmacy University \u00bbSs. Cyril and Methodius\u00ab 1000 Skopje, Republic of Macedonia","institution_ids":["https://openalex.org/I76245029"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":900,"currency":"EUR","value_usd":970},"apc_paid":{"value":900,"currency":"EUR","value_usd":970},"fwci":0.2743,"has_fulltext":true,"cited_by_count":16,"citation_normalized_percentile":{"value":0.49401163,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"65","issue":"1","first_page":"53","last_page":"63"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T13023","display_name":"Synthesis of Organic Compounds","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/coumarins","display_name":"coumarins","score":0.9229999780654907},{"id":"https://openalex.org/keywords/isoxazoles","display_name":"isoxazoles","score":0.8930000066757202},{"id":"https://openalex.org/keywords/thiazole","display_name":"thiazole","score":0.9990000128746033},{"id":"https://openalex.org/keywords/metastatic-breast-cancer","display_name":"metastatic breast cancer","score":0.8450000286102295},{"id":"https://openalex.org/keywords/bone-metastases","display_name":"bone metastasis","score":0.8349999785423279},{"id":"https://openalex.org/keywords/lung-metastasis","display_name":"lung metastasis","score":0.9990000128746033},{"id":"https://openalex.org/keywords/antiproliferative-activity","display_name":"antiproliferative activity","score":0.9879999756813049},{"id":"https://openalex.org/keywords/anticancer-agents","display_name":"anticancer agents","score":0.6230000257492065},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.7039999961853027},{"id":"https://openalex.org/keywords/4-hydroxycoumarin","display_name":"4-hydroxycoumarin","score":0.824999988079071},{"id":"https://openalex.org/keywords/cell-viability","display_name":"cell viability","score":0.49000000953674316}],"concepts":[{"id":"https://openalex.org/C2778464347","wikidata":"https://www.wikidata.org/wiki/Q413426","display_name":"Thiazole","level":2,"score":0.8481429815292358},{"id":"https://openalex.org/C2781338262","wikidata":"https://www.wikidata.org/wiki/Q111812","display_name":"Coumarin","level":2,"score":0.8394304513931274},{"id":"https://openalex.org/C2776568683","wikidata":"https://www.wikidata.org/wiki/Q23005640","display_name":"Moiety","level":2,"score":0.6994595527648926},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6688031554222107},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.5616494417190552},{"id":"https://openalex.org/C2776300020","wikidata":"https://www.wikidata.org/wiki/Q422423","display_name":"Bromide","level":2,"score":0.5515581369400024},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.4770074188709259},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4724854826927185},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.41380515694618225},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.36771121621131897},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3515843152999878},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2892938554286957},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.14088815450668335},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.13429132103919983},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.1193183958530426}],"mesh":[{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D001859","descriptor_name":"Bone Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001859","descriptor_name":"Bone Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D002470","descriptor_name":"Cell Survival","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D003374","descriptor_name":"Coumarins","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003374","descriptor_name":"Coumarins","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D003374","descriptor_name":"Coumarins","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007555","descriptor_name":"Isoxazoles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007555","descriptor_name":"Isoxazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D007555","descriptor_name":"Isoxazoles","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000556","qualifier_name":"secondary","is_major_topic":false},{"descriptor_ui":"D013844","descriptor_name":"Thiazoles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D013844","descriptor_name":"Thiazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D013844","descriptor_name":"Thiazoles","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015110","descriptor_name":"4-Hydroxycoumarins","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D015110","descriptor_name":"4-Hydroxycoumarins","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D020128","descriptor_name":"Inhibitory Concentration 50","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":7,"locations":[{"id":"doi:10.1515/acph-2015-0002","doi":"https://doi.org/10.1515/acph-2015-0002","is_oa":true,"landing_page_url":"https://doi.org/10.1515/acph-2015-0002","pdf_url":"https://sciendo.com/pdf/10.1515/acph-2015-0002","source":{"id":"https://openalex.org/S6622299","display_name":"Acta Pharmaceutica","issn_l":"1330-0075","issn":["1330-0075","1846-9558"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","medline","norway-1","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320322","host_organization_name":"De Gruyter Open","host_organization_lineage":["https://openalex.org/P4310320322","https://openalex.org/P4310313990"],"host_organization_lineage_names":["De Gruyter Open","De Gruyter"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta Pharmaceutica","raw_type":"journal-article"},{"id":"pmid:25781704","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25781704","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta pharmaceutica (Zagreb, Croatia)","raw_type":"Comparative Study"},{"id":"pmh:oai:www.zora.uzh.ch:123218","doi":null,"is_oa":true,"landing_page_url":"https://www.zora.uzh.ch/id/eprint/123218/7/acph-2015-0002.pdf","pdf_url":"https://www.zora.uzh.ch/id/eprint/123218/7/acph-2015-0002.pdf","source":{"id":"https://openalex.org/S4306401281","display_name":"Zurich Open Repository and Archive (University of Zurich)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I202697423","host_organization_name":"University of Zurich","host_organization_lineage":["https://openalex.org/I202697423"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Ballazhi, Lulzime; Popovski, Emil; Jashari, Ahmed; Imeri, Faik; Ibrahimi, Ibrahim; Mikhova, Bozhana; Mladenovska, Kristina (2015). Potential antiproliferative effect of isoxazolo- and thiazolo coumarin derivatives on breast cancer mediated bone and lung metastases. Acta Pharmaceutica, 65(1):53-63.","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:doaj.org/article:540062d9547a427191e9bf5bfb782107","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/540062d9547a427191e9bf5bfb782107","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Acta Pharmaceutica, Vol 65, Iss 1, Pp 53-63 (2015)","raw_type":"article"},{"id":"pmh:oai:hrcak.srce.hr:128389","doi":null,"is_oa":true,"landing_page_url":"http://hrcak.srce.hr/128389","pdf_url":null,"source":{"id":"https://openalex.org/S4306400677","display_name":"Hr\u010dak Portal of scientific journals of Croatia (University Computing Centre)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210104502","host_organization_name":"United Nations University","host_organization_lineage":["https://openalex.org/I4210104502"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Acta Pharmaceutica","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:www.zora.uzh.ch:20.500.14742/118898","doi":null,"is_oa":true,"landing_page_url":"https://www.zora.uzh.ch/handle/20.500.14742/118898","pdf_url":null,"source":{"id":"https://openalex.org/S4306401281","display_name":"Zurich Open Repository and Archive (University of Zurich)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I202697423","host_organization_name":"University of Zurich","host_organization_lineage":["https://openalex.org/I202697423"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Ballazhi, L., Popovski, E., Jashari, A., Imeri, F., Ibrahimi, I., Mikhova, B., & Mladenovska, K. (2015). Potential antiproliferative effect of isoxazolo- and thiazolo coumarin derivatives on breast cancer mediated bone and lung metastases. Acta Pharmaceutica, 65, 53\u201363. https://doi.org/10.1515/acph-2015-0002","raw_type":"Journal Article"},{"id":"doi:10.5167/uzh-123218","doi":"https://doi.org/10.5167/uzh-123218","is_oa":true,"landing_page_url":"https://doi.org/10.5167/uzh-123218","pdf_url":null,"source":{"id":"https://openalex.org/S4306401281","display_name":"Zurich Open Repository and Archive (University of Zurich)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I202697423","host_organization_name":"University of Zurich","host_organization_lineage":["https://openalex.org/I202697423"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"}],"best_oa_location":{"id":"doi:10.1515/acph-2015-0002","doi":"https://doi.org/10.1515/acph-2015-0002","is_oa":true,"landing_page_url":"https://doi.org/10.1515/acph-2015-0002","pdf_url":"https://sciendo.com/pdf/10.1515/acph-2015-0002","source":{"id":"https://openalex.org/S6622299","display_name":"Acta Pharmaceutica","issn_l":"1330-0075","issn":["1330-0075","1846-9558"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","medline","norway-1","poland-40","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320322","host_organization_name":"De Gruyter Open","host_organization_lineage":["https://openalex.org/P4310320322","https://openalex.org/P4310313990"],"host_organization_lineage_names":["De Gruyter Open","De Gruyter"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta Pharmaceutica","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W15106902.pdf","grobid_xml":"https://content.openalex.org/works/W15106902.grobid-xml"},"referenced_works_count":32,"referenced_works":["https://openalex.org/W18304185","https://openalex.org/W935185763","https://openalex.org/W1685527246","https://openalex.org/W1914423488","https://openalex.org/W1964244592","https://openalex.org/W1971491446","https://openalex.org/W1986471913","https://openalex.org/W1996976336","https://openalex.org/W2000728148","https://openalex.org/W2007833797","https://openalex.org/W2008926885","https://openalex.org/W2012503217","https://openalex.org/W2044823923","https://openalex.org/W2058605858","https://openalex.org/W2082833890","https://openalex.org/W2088338909","https://openalex.org/W2089585797","https://openalex.org/W2108077406","https://openalex.org/W2113500453","https://openalex.org/W2118940014","https://openalex.org/W2119995276","https://openalex.org/W2123820095","https://openalex.org/W2148738581","https://openalex.org/W2164621703","https://openalex.org/W2165999332","https://openalex.org/W2168457230","https://openalex.org/W2171192035","https://openalex.org/W2945792041","https://openalex.org/W2950100142","https://openalex.org/W4233287607","https://openalex.org/W4285719527","https://openalex.org/W6910414842"],"related_works":["https://openalex.org/W2000728148","https://openalex.org/W4415489830","https://openalex.org/W2907064064","https://openalex.org/W3043025911","https://openalex.org/W2727288271","https://openalex.org/W4399043238","https://openalex.org/W2899508715","https://openalex.org/W2183475670","https://openalex.org/W7149321862","https://openalex.org/W2891764087"],"abstract_inverted_index":{"The":[0,83],"study":[1],"highlights":[2],"the":[3,7,26,60,76,91,107,115],"current":[4],"progress":[5],"in":[6,19,36,41,114],"development":[8],"of":[9,43,73],"coumarin":[10,27],"scaffolds":[11],"for":[12],"drug":[13],"discovery":[14],"as":[15],"novel":[16],"anticancer":[17],"agents":[18],"metastatic":[20,54],"breast":[21,55],"cancer.":[22],"Eight":[23],"compounds,":[24],"combining":[25],"core":[28],"and":[29,34,51,70,75,87],"five":[30],"membered":[31],"heterocycles":[32],"(isoxazoles":[33],"thiazoles)":[35],"hydrazinyldiene-":[37],"-chroman-2,4-diones,":[38],"were":[39,81],"characterized":[40],"terms":[42],"a":[44,96],"potential":[45],"antiproliferative":[46],"effect":[47],"on":[48],"bone":[49],"(SCP1833)":[50],"lung":[52],"(SCP4175)":[53],"cancer":[56],"cell":[57,127],"lines":[58,128],"using":[59],"3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium":[61],"bromide":[62],"assay.":[63],"Cell":[64],"viability":[65],"was":[66],"evaluated":[67],"after":[68],"48":[69],"72":[71],"h":[72],"treatment":[74],"50":[77],"%":[78],"inhibitory":[79],"concentrations":[80],"determined.":[82],"results":[84],"demonstrated":[85],"dose-":[86],"time-dependent":[88],"activity,":[89],"with":[90,101],"most":[92],"potent":[93],"molecules":[94,119],"having":[95],"thiazole":[97,116],"moiety,":[98],"without":[99],"or":[100],"additional":[102],"methyl":[103],"group(s)":[104],"attached":[105],"to":[106,130],"carbon(s)":[108],"at":[109],"position(s)":[110],"5":[111],"and/or":[112],"4":[113],"ring.":[117],"These":[118],"possessed":[120],"significantly":[121],"higher":[122],"potency":[123],"against":[124],"both":[125],"test":[126],"compared":[129],"4-hydroxycoumarin.":[131]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":3},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
